Get started
Author

Jo‐Ann I. Sheppard

Observed names: J Sheppard, J. I. Sheppard, J.I. SHEPPARD, J.I. Sheppard, Jo-Ann I. Sheppard, Jo-Ann Sheppard, Joann Sheppard
Institution: McMaster University
Observed institutions: MedStar Washington Hospital Center, University of Waterloo, University of California, Los Angeles, Vancouver General Hospital, Universität Greifswald, Hamilton Regional Laboratory Medicine Program, St. Joseph’s Healthcare Hamilton, Hamilton Health Sciences, University of Gothenburg, McMaster University
ORCID: 0000-0002-4402-7809
Observed ORCID: 0000-0002-4402-7809
OpenAlex ID: A5059577985
Impact of the patient population on the risk for heparin-induced thrombocytopenia
2000 · Theodore E. Warkentin, Jo-Ann I. Sheppard, et al. · Blood · 918
Quantitative interpretation of optical density measurements using PF4‐dependent enzyme‐immunoassays
2008 · T.E. WARKENTIN, J.I. SHEPPARD, et al. · Journal of Thrombosis and Haemostasis · 358
Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia
2006 · Theodore E. Warkentin, Jo-Ann I. Sheppard, et al. · Blood · 296
PDF
Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin
2005 · Theodore E. Warkentin, Richard J. Cook, et al. · Blood · 282
PDF
Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: How much class do we need?
2005 · Theodore E. Warkentin, Jo-Ann I. Sheppard, et al. · Journal of Laboratory and Clinical Medicine · 260
Studies of the immune response in heparin-induced thrombocytopenia
2009 · Theodore E. Warkentin, Jo-Ann I. Sheppard, et al. · Blood · 178
Fondaparinux treatment of acute heparin‐induced thrombocytopenia confirmed by the serotonin‐release assay: a 30‐month, 16‐patient case series
2011 · T.E. WARKENTIN, M. PAI, et al. · Journal of Thrombosis and Haemostasis · 139
Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation
2005 · Andreas Greinacher, Sharon Craven, et al. · Thrombosis and Haemostasis · 128
The temporal profile of the anti-PF4/heparin immune response
2008 · Andreas Greinacher, Thomas Kohlmann, et al. · Blood · 116
PDF
Testing for Heparin-Induced Thrombocytopenia Antibodies
2006 · Theodore E. Warkentin, Jo-Ann I. Sheppard · Transfusion Medicine Reviews · 115
Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities
2014 · Theodore E. Warkentin, Jo-Ann I. Sheppard, et al. · Blood · 99
Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin
2014 · Theodore E. Warkentin, Jo-Ann I. Sheppard · Blood · 94
Heparin‐induced thrombocytopenia – therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4–heparin complexes
2008 · K. KRAUEL, B. FÜRLL, et al. · Journal of Thrombosis and Haemostasis · 87
Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like Antibodies
2023 · Theodore E. Warkentin, Jacquelyn Baskin-Miller, et al. · New England Journal of Medicine · 85
Heparin‐induced thrombocytopenia: towards standardization of platelet factor 4/heparin antigen tests
2010 · A. GREINACHER, T. ITTERMANN, et al. · Journal of Thrombosis and Haemostasis · 84
Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL ® HIT-Ab (PF4-H) ] for the diagnosis of immune heparin-induced thrombocytopenia
2017 · Theodore E. Warkentin, Jo-Ann I. Sheppard, et al. · Thrombosis Research · 74
Heparin-Induced Thrombocytopenia in Medical Surgical Critical Illness
2013 · Theodore E. Warkentin, Jo-Ann I. Sheppard, et al. · CHEST Journal · 72
Heparin-induced thrombocytopenia in the critically ill: Interpreting the 4Ts test in a randomized trial
2014 · Mark Crowther, Deborah Cook, et al. · Journal of Critical Care · 58
Serotonin‐release assay‐negative heparin‐induced thrombocytopenia
2019 · Theodore E. Warkentin, Ishac Nazy, et al. · American Journal of Hematology · 57
PDF
High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT
2018 · Theodore E. Warkentin, Jo-Ann I. Sheppard, et al. · Blood · 53
PDF
VITT-like Monoclonal Gammopathy of Thrombotic Significance
2025 · Jing Jing Wang, Theodore E. Warkentin, et al. · New England Journal of Medicine · 51
High‐dose intravenous immunoglobulin to treat spontaneous heparin‐induced thrombocytopenia syndrome
2019 · Elan Mohanty, Salik Nazir, et al. · Journal of Thrombosis and Haemostasis · 51
PDF
Adherent platelet morphology on adsorbed fibrinogen: Effects of protein incubation time and albumin addition
1994 · J. I. Sheppard, W. G. McClung, et al. · Journal of Biomedical Materials Research · 51
The Role for Optical Density in Heparin-Induced Thrombocytopenia
2015 · Chee M. Chan, Christian J. Woods, et al. · CHEST Journal · 48
No significant improvement in diagnostic specificity of an anti‐PF4/polyanion immunoassay with use of high heparin confirmatory procedure
2005 · T.E. WARKENTIN, J.I. SHEPPARD · Journal of Thrombosis and Haemostasis · 48
Works count: 65
Citation count: 4,407
H-index: 31
I10-index: 50
Year
Topic
Type